Cemtrex Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Cemtrex heeft een totaal eigen vermogen van $352.9K en een totale schuld van $20.3M, wat de schuld-eigenvermogensverhouding op 5747.7% brengt. De totale activa en totale passiva bedragen respectievelijk $43.8M en $43.5M.

Belangrijke informatie

5,747.7%

Verhouding schuld/eigen vermogen

US$20.28m

Schuld

Rente dekkingsratio	n/a
Contant	US$6.48m
Aandelen	US$352.92k
Totaal verplichtingen	US$43.47m
Totaal activa	US$43.83m

Recente financiële gezondheidsupdates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $26.4M ) C421 } overtreffen de korte termijn passiva ( $14.0M ).

Langlopende schulden: De kortetermijnactiva van C421 ( $26.4M ) dekken de langetermijnschulden ( $29.5M ) niet.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 3911% ) C421 wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van C421 is de afgelopen 5 jaar gestegen van 74.4% naar 5747.7%.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: C421 heeft op basis van de huidige vrije kasstroom voldoende kasstroom voor meer dan een jaar.

Voorspelling contante baan: C421 heeft voldoende kasruimte voor 1.3 jaar als de vrije kasstroom blijft dalen met een historisch percentage van 3 % per jaar.

Cemtrex Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Cemtrex Announces 1-For-35 Reverse Stock Split to Regain Compliance with the Minimum Closing Bid Price Requirement

The Nasdaq Stock Market LLC Grants Cemtrex an Extension to Regain Compliance with the Minimum Stockholder’s Equity Requirement

Cemtrex Receives Notification Letter from Nasdaq Due to Non-Compliance with the Minimum $2.5 Million Stockholder’s Equity Requirement for Continued Listing on The Nasdaq Capital Market

Cemtrex Receives Notification Letter from Nasdaq Due to Non-Compliance with Minimum Bid Price Requirement for Continued Listing on The Nasdaq Capital Market

Cemtrex Receives a Letter from the Nasdaq Hearings Panel

Cemtrex Regains Compliance with Nasdaq Listing Requirements

Recent updates

Cemtrex Announces 1-For-35 Reverse Stock Split to Regain Compliance with the Minimum Closing Bid Price Requirement

The Nasdaq Stock Market LLC Grants Cemtrex an Extension to Regain Compliance with the Minimum Stockholder’s Equity Requirement

Cemtrex Receives Notification Letter from Nasdaq Due to Non-Compliance with the Minimum $2.5 Million Stockholder’s Equity Requirement for Continued Listing on The Nasdaq Capital Market

Third quarter 2024 earnings released: US$0.29 loss per share (vs US$1.29 loss in 3Q 2023)

Cemtrex, Inc. to Report Q3, 2024 Results on Aug 14, 2024

Cemtrex Receives Notification Letter from Nasdaq Due to Non-Compliance with Minimum Bid Price Requirement for Continued Listing on The Nasdaq Capital Market

Cemtrex, Inc., Annual General Meeting, May 16, 2024

Cemtrex, Inc., Annual General Meeting, May 16, 2024

Cemtrex, Inc. to Report Q1, 2024 Results on Feb 12, 2024

Cemtrex, Inc. has filed a Follow-on Equity Offering in the amount of $10.35 million.

Cemtrex, Inc. to Report Q4, 2023 Results on Dec 21, 2023

Cemtrex Receives a Letter from the Nasdaq Hearings Panel

Cemtrex, Inc. to Report Q3, 2023 Results on Aug 10, 2023

Cemtrex, Inc. acquired Heisey Mechanical, Ltd. for $2.4 million.

Cemtrex Regains Compliance with Nasdaq Listing Requirements

Cemtrex, Inc. to Report Q1, 2023 Results on Feb 14, 2023

Cemtrex Receives Non-Compliance Notification Letter from Nasdaq

Cemtrex Announces Reverse Split to Regain NASDAQ Compliance

Full year 2022 earnings released: US$0.52 loss per share (vs US$0.025 profit in FY 2021)

Cemtrex, Inc. Announces Resignation of Chris Wagner as Board Member

Cemtrex, Inc., Annual General Meeting, Sep 30, 2022

Third quarter 2022 earnings released: US$0.026 loss per share (vs US$0.059 profit in 3Q 2021)

Cemtrex Inc. Hires Haim Shain as Senior Vp, Product Management

Cemtrex, Inc. to Report Q3, 2022 Results on Aug 15, 2022

Nasdaq Grants Extension to Cemtrex to Regain Compliance

Second quarter 2022 earnings released: US$0.20 loss per share (vs US$0.13 profit in 2Q 2021)

Cemtrex, Inc. announced delayed 10-Q filing

Cemtrex, Inc. Announces CFO Changes

Cemtrex Receives Notification Letter from the Listing Qualifications Department of Nasdaq

Cemtrex Announces Receipt of Nasdaq Listing Delinquency Letter and Subsequently Regains Compliance

Cemtrex, Inc. announced delayed annual 10-K filing

Independent Director Sunil Verma has left the company

Third quarter 2021 earnings released: EPS US$0.059 (vs US$0.41 loss in 3Q 2020)

Cemtrex Announces Receipt of Nasdaq Listing Delinquency Letter

Cemtrex, Inc. announced delayed 10-Q filing

Cemtrex, Inc. announced delayed 10-Q filing

Cemtrex, Inc. Announces Resignation of Raju Panjwani from the Company’s Board and Audit Committee

Cemtrex, Inc. Announces Resignation of Raju Panjwani as Board Member

Cemtrex, Inc. Appoints Christopher C. Moore as Chief Financial Officer

Cemtrex, Inc. announced delayed annual 10-K filing

New 90-day high: €1.31

Cemtrex, Inc. Launches Next Generation SmartDesk for Laptop Users

Cemtrex Inc. Announces Engagements with Major Consumer Brands to Utilize AR/VR in Digital Marketing Campaigns

Cemtrex, Inc. (NasdaqCM:CETX) acquired an unknown minority stake in MasterpieceVR.

New 90-day high: €1.12

New 90-day low: €0.82

Cemtrex, Inc. (NasdaqCM:CETX) acquired Virtual Driver Interactive, Inc.

Cemtrex, Inc. Announces Resignation of Aron Govil as Director

New 90-day low: €0.83

New 90-day low - €0.98

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse van de cashflow

Ontdek gezonde bedrijven